Recombinant chimeric eucaryotic expression vector Cb1-Grb7(SH2)-RING and use of anti-tumour gene drug
A technology of chimeric molecules and expression plasmids, which can be used in anti-tumor drugs, recombinant DNA technology, gene therapy, etc., and can solve the problem of not using recombinant Cbl ubiquitin ligase.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0033] The following is the construction and identification of the recombinant chimeric Cbl ubiquitin ligase Cbl-Grb7(SH2)-RING eukaryotic expression plasmid (pcDNA3.1(+)-Cbl-Grb7(SH2)-RING) given by the inventor and its identification Inhibitory effect of plasmids on the growth of EGFR and HER2 positive tumor cells.
[0034] 1. Construction of recombinant chimeric Cbl ubiquitin ligase Cbl-Grb7(SH2)-RING eukaryotic expression plasmid
[0035] 1.1 Experimental materials
[0036] Both restriction enzymes and T4 ligase were purchased from Dalian Baosheng Biological Co., Ltd., and the eukaryotic cell expression plasmid pcDNA3.1(+) was purchased from Invitrogen Company. The plasmid map of pcDNA3.1(+) is shown in Figure 1. In the figure, PCMV: CMV promoter, base 232-819, T7: T7 promoter / primer site, base 863-882, polyclonal restriction site: base 895-1010, BGHpA: bovine Growth hormone polyadenylation sequence, 1028-1252 bases, f1 ori: f1 start site, 1296-1726 bases, SV40 ori: SV40...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 